Animal Parasiticides Market

Elanco Animal Health Incorporated (US) and Merck & Co., Inc. (US) are the Prominent Players in the Animal Parasiticides Market

The global animal parasiticides market is projected to reach USD 13.7 billion by 2026 from USD 9.7 billion in 2021, at a CAGR of 7.2% during the forecast period. Factors such as the rising demand for animal-derived food products, increasing investments by private players, growing concerns of zoonotic diseases, regulations for preventing the spread of animal diseases, growing companion animal ownership rates, and rising animal health expenditure are driving the growth of the animal parasiticides market. However, a shift toward vegetarianism and restrictions on the use of parasiticides in food-producing animals are expected to restrain the growth of this market during the forecast period.

The prominent players in the animal parasiticides market are Boehringer Ingelheim (Germany), Elanco Animal Health Incorporated (US), Merck & Co., Inc. (US), Zoetis Inc. (US), Virbac (France), Vetoquinol S.A. (France), PetIQ, Inc. (US), SeQuent Scientific Ltd. (India), ECO Animal Health Group plc (UK), Ceva Santé Animale (France), Chanelle Pharma (Ireland), Abbey Animal Health Pty Ltd. (Australia), Norbrook (UK), SmartVet Holdings (US), Krka Group (Slovenia) and Bimeda Animal Health (Ireland) among others. These players have adopted various growth strategies such as acquisition, product launches, and expansion to increase their presence and reach in the medical device contract manufacturing market.

To know about the assumptions considered for the study download the pdf brochure

ELANCO ANIMAL HEALTH INCORPORATED

Elanco Animal Health Incorporated accounted for an estimated share of 23-25% of the animal parasiticides market in 2020. To secure its position in the global animal parasiticides market, the company focuses on expanding and strengthening its partnerships with existing customers, enhancing operations and quality, and enhancing product scope, capabilities, and expertise. The company achieves its targets through a number of organic and inorganic growth strategies, such as product launches, expansions, acquisitions, agreements, partnerships, collaborations, and divestitures. In August 2019, Elanco acquired Bayer’s Animal Health business. This acquisition doubled Elanco’s animal health business and broadened the company’s portfolio.

BOEHRINGER INGELHEIM

Boehringer Ingelheim accounted for an estimated share of 21-23% of the animal parasiticides market in 2020. The company offers a diverse product line for animal parasiticides in different formulations to meet the unaddressed needs of pets and livestock animals. Boehringer Ingelheim’s core brands such as NexGard, followed by Frontline and Heartgard, are the foundations of its success in the companion animals segment. The company’s strong focus on R&D and investments in collaborations, partnerships, and acquisitions have helped the company to secure a leading position in the market. The company also focuses on expansions to strengthen its geographic footprint. For instance, in August 2019, Boehringer Ingelheim opened a Health Management Center in China.

ZOETIS INC.

Zoetis accounted for an estimated share of 12-13% of the animal parasiticides market in 2020. The company provides highly diversified products for a wide range of animal species. To maintain its position in the parasiticides segment, Zoetis focuses on providing innovative products and enhancing its R&D capabilities to address the needs of animal health. Additionally, the company has well-invested assets for which it has developed into a global company with subsidiaries in every continent. This gives the company a strong competitive advantage in terms of distribution networks and production facilities.

MERCK & CO., INC.

Merck accounted for an estimated share of 9-10% of the animal parasiticides market in 2020. The company’s strong focus to broaden its animal parasiticides product portfolio through investments in the form of collaborations and partnerships are driving its growth in the market. For instance, in July 2020, Merck acquired the US rights from Virbac for the SENTINEL brand of combination parasiticides used to protect dogs against fleas and common intestinal parasites. This helped Merck offer a comprehensive portfolio of parasiticide products for companion animals.

Related Reports:

Animal Parasiticides Market by Type (Ectoparasiticides (Pour-ons & Spot-ons, Tablets, Sprays), Endoparasiticides (Oral Solids, Injectables, Feed Additives), Endectocides), Animal (Companion Animals, Livestock), End User, & Region- Global Forecast to 2026

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
PH 2460
RI Published ON
10/5/2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Animal Parasiticides Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved